Results 21 to 30 of about 850,017 (337)

Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines

Expert Review of Vaccines, 2023
Introduction Approximately half of the 13.4 billion COVID-19 vaccine doses administered globally were inactivated or viral vector platforms. The harmonization and optimization of vaccine regimens has become a key focus of policymakers and health-care ...
Anthony M. Marchese, Raj Kalkeri, Muruga Vadivale, Nungruthai Suntronwong, Seth Toback, Yong Poovorawan   +5 more
doaj   +1 more source

Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting

Frontiers in Immunology, 2021
While the immunogenicity of inactivated vaccines against coronavirus disease 2019 (COVID‐19) has been characterized in several well-conducted clinical trials, real-world evidence concerning immune responses against severe acute respiratory syndrome ...
Ziwei Li, Tiandan Xiang, B. Liang, Huihong Deng, Hua Wang, Xue-mei Feng, Xufeng Quan, Xiaoyan Wang, Sumeng Li, Sihong Lu, Xuecheng Yang, Baoju Wang, Gennadiy Zelinskyy, M. Trilling, K. Sutter, Mengji Lu, U. Dittmer, Dongliang Yang, Xin Zheng, Jia Liu   +19 more
semanticscholar   +1 more source

Methodology of Purification of Inactivated Cell-Culture-Grown SARS-CoV-2 Using Size-Exclusion Chromatography

Vaccines, 2022
Various types of COVID-19 vaccines, including adenovirus, mRNA, and inactivated ones, have been developed and approved for clinical use worldwide. Inactivated vaccines are produced using a proven technology that is widely used for the production of ...
Anastasia A. Kovpak, Anastasia N. Piniaeva, Oleg A. Gerasimov, Irina O. Tcelykh, Mayya Y. Ermakova, Anna N. Zyrina, Dmitry V. Danilov, Yury Y. Ivin, Liubov I. Kozlovskaya, Aydar A. Ishmukhametov   +9 more
doaj   +1 more source

Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report

Clinical Case Reports, 2023
Key Clinical Message In patients with acute symptoms such as pain, swelling, and erythema of the upper extremities shortly after receiving COVID‐19 vaccines, even inactivated virus vaccines, these symptoms may indicate thrombosis, which may be due to the
Ali Riazi, Masood Faghih Dinevari, Samaneh Abbasian, Amirreza Jabbaripour Sarmadian   +3 more
doaj   +1 more source

Nitric Oxide Production and Fc Receptor-Mediated Phagocytosis as Functional Readouts of Macrophage Activity upon Stimulation with Inactivated Poultry Vaccines In Vitro

Vaccines, 2020
Vaccine batches must pass routine quality control to confirm that their ability to induce protection against disease is consistent with batches of proven efficacy from development studies.
Robin H.G.A. van den Biggelaar, Willem van Eden, Victor P.M.G. Rutten, Christine A. Jansen   +3 more
doaj   +1 more source

EVALUATION OF DIFFERENT NEWCASTLE DISEASE VIRUS VACCINATION REGIMES AGAINST CHALLENGE WITH RECENTLY ISOLATED GENOTYPE VII VIRUS FROM EGYPT

Slovenian Veterinary Research, 2023
Newcastle disease virus (NDV) genotype VII is incriminated in the currently circulating NDV outbreaks in the Middle East region. In this study, evaluation of different vaccination regimes including genetically-matched or mismatched vaccines to the ...
Mohamed M. Megahed, Wala Mohamed, Ola Adel Hassanin   +2 more
doaj   +1 more source

Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment [PDF]

, 2014
There is an urgent need for rapid methods to develop vaccines in response to emerging viral pathogens. Whole inactivated virus (WIV) vaccines represent an ideal strategy for this purpose; however, a universal method for producing safe and immunogenic ...
Achilefu, Samuel, Chen, Alexander, Donthi, Nisha, Hsieh, Wen-Han, Hung, Chien-Fu, Knoff, Jayne, La, Victor, Li, Yen-Der, Tsen, Kong-Thon, Tsen, Shaw-Wei David, Wu, Tzyy-Choou   +10 more
core   +2 more sources

Development of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodies [PDF]

, 2009
Porcine reproductive and respiratory syndrome virus (PRRSV) can induce reproductive disorders and is involved in the porcine respiratory disease complex, causing tremendous economic losses to the swine industry.
Delputte, Peter, Delrue, Iris, Geldhof, Marc, Nauwynck, Hans, Vanhee, Merijn   +4 more
core   +3 more sources

Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges

BMC Veterinary Research, 2012
Background The porcine reproductive and respiratory syndrome virus (PRRSV) is a rapidly evolving pathogen of swine. At present, there is a high demand for safe and more effective vaccines that can be adapted regularly to emerging virus variants. A recent
Geldhof Marc F, Vanhee Merijn, Van Breedam Wander, Van Doorsselaere Jan, Karniychuk Uladzimir U, Nauwynck Hans J   +5 more
doaj   +1 more source

Development of a Double-Antibody Sandwich ELISA for Rapid Detection of the MCP Antigen Concentration in Inactivated ISKNV Vaccines

Vaccines, 2021
Infectious spleen and kidney necrosis virus (ISKNV) resulted in severe systemic diseases with high morbidity and mortality in Siniperca chuatsi. Vaccination is the primary method for effective prevention and control of these diseases.
Hongru Liang, Lixi Zhang, Xiaozhe Fu, Qiang Lin, Lihui Liu, Yinjie Niu, Xia Luo, Zhibin Huang, Ningqiu Li   +8 more
doaj   +1 more source